In CML MYC-overexpressing cells, the MYC:MAX heterodimer was found to bind to BCR promoter region in four binding sites, leading to upregulation of both BCR and the fusion protein at mRNA and protein level. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.